Warning letter
Leimax, Corp.: warning letter of Oct 7, 2022
FDA warning letter 633364 · Division of Northeast Imports
Key facts
| Reference number | 633364 |
|---|---|
| Company | Leimax, Corp. |
| Subject | Foreign Supplier Verification Program (FSVP) |
| Issue date | Oct 7, 2022 |
| Posted date | Jan 24, 2023 |
| Issuing office | Division of Northeast Imports |
| Product type | Food/Cosmetics |
| CFR sections cited | 1, 1.500, 1.512, 1.512(b)(3)(i), 1.512(b)(1)(i) |
| Inspection city | Yonkers |
| Inspection ZIP | 10701 |
| Inspection start date | Apr 5, 2022 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: